MARKET

ENVB

ENVB

Enveric Biosciences Inc
NASDAQ
5.10
+0.05
+0.89%
Opening 14:43 12/19 EST
OPEN
4.950
PREV CLOSE
5.06
HIGH
5.13
LOW
4.900
VOLUME
48.95K
TURNOVER
--
52 WEEK HIGH
96.30
52 WEEK LOW
4.550
MARKET CAP
3.04M
P/E (TTM)
-0.0539
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ENVB last week (1208-1212)?
Weekly Report · 4d ago
Enveric Biosciences Secures $3.1M Through Warrant Exercise
TipRanks · 6d ago
Enveric Biosciences Raises $3.1 Million Through Warrant Exercise and New Warrant Issuance
Reuters · 6d ago
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds
Barchart · 12/12 15:46
Enveric Biosciences trading resumes
TipRanks · 12/11 19:00
Enveric Biosciences Announces Immediate Warrant Exercise, Raising ~$3.1M Gross Proceeds At Reduced $7.05/Share Price
Benzinga · 12/11 18:46
Enveric Biosciences trading halted, volatility trading pause
TipRanks · 12/11 18:45
Enveric Biosciences Raises $3.1 Million Through Warrant Exercise
Reuters · 12/11 18:43
More
About ENVB
Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. Leveraging its discovery and development platform, the Psybrary platform, which houses proprietary information on the use and development of existing and novel molecules for specific mental health indications, the Company seeks to develop a robust intellectual property portfolio of drug candidates. Its lead molecule, EB-003, is a neuroplastogen designed to promote neuroplasticity, without inducing hallucinations, in patients suffering from difficult-to-address mental health disorders. The Company is focused on advancing EB-003 towards clinical trials for the treatment of neuropsychiatric disorders while out-licensing other Psybrary platform drug candidates to third-party licensees and advancing non-competitive market strategies for patient care.

Webull offers Enveric Biosciences Inc stock information, including NASDAQ: ENVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENVB stock methods without spending real money on the virtual paper trading platform.